O

Oragenics
D

OGEN

0.28220
USD
-0.00
(-1.26%)
Market Closed
Volume
0
EPS
-11
Div Yield
-
P/E
-0
Market Cap
2,443,590
OverviewSignalsIdeasNews
Related Instruments
    O
    OBE
    -0.14000
    (-2.49%)
    5.48000 USD
    O
    OESX
    -0.01620
    (-1.82%)
    0.87370 USD
    O
    OGE
    1.000
    (2.39%)
    42.800 USD
    O
    OVBC
    -0.360
    (-1.44%)
    24.670 USD
    More
News

Title: Oragenics

Sector: Healthcare
Industry: Biotechnology
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.